GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wakamoto Pharmaceutical Co Ltd (TSE:4512) » Definitions » 14-Day RSI

Wakamoto Pharmaceutical Co (TSE:4512) 14-Day RSI : 52.97 (As of Apr. 01, 2025)


View and export this data going back to 1949. Start your Free Trial

What is Wakamoto Pharmaceutical Co 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2025-04-01), Wakamoto Pharmaceutical Co's 14-Day RSI is 52.97.

The industry rank for Wakamoto Pharmaceutical Co's 14-Day RSI or its related term are showing as below:

TSE:4512's 14-Day RSI is ranked worse than
81.2% of 1080 companies
in the Drug Manufacturers industry
Industry Median: 44.505 vs TSE:4512: 52.97

Competitive Comparison of Wakamoto Pharmaceutical Co's 14-Day RSI

For the Drug Manufacturers - Specialty & Generic subindustry, Wakamoto Pharmaceutical Co's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wakamoto Pharmaceutical Co's 14-Day RSI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wakamoto Pharmaceutical Co's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Wakamoto Pharmaceutical Co's 14-Day RSI falls into.


;
;

Wakamoto Pharmaceutical Co  (TSE:4512) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wakamoto Pharmaceutical Co  (TSE:4512) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Wakamoto Pharmaceutical Co 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Wakamoto Pharmaceutical Co's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Wakamoto Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
2-2-2, Nihonbashi Honcho, Chuo-ku, Tokyo, JPN, 103-8330
Wakamoto Pharmaceutical Co Ltd is the pharmaceutical company based in Japan. It is engaged in the research and development, production and sale of ethical drugs and non-prescription drugs. The company specializes in therapeutic and diagnostic agents for ophthalmic disorders. It offers Strong Wakamoto, a gastrointestinal drug for digestion, the intestinal function controlling, and nutritional supply.

Wakamoto Pharmaceutical Co Headlines

No Headlines